Welcome to the AstraZeneca | Daiichi-Sankyo Sponsored Lunch Symposium
The Changing Paradigm for Treating HER2+ eBC.
You’re invited to an engaging and practical symposium exploring the evolving management of high-risk HER2-positive early breast cancer (eBC). As treatment options continue to expand across the neoadjuvant and adjuvant settings, clinicians are increasingly faced with complex decisions about tailoring therapy to achieve the best outcomes for patients.
Join internationally recognised experts Professor Nadia Harbeck, Dr Antonia Pearson, Professor Bruce Mann and Associate Professor Gillian Lamoury as they present:
- An overview of the HER2+ eBC landscape.
- Real-world case studies exploring both the high-risk neoadjuvant setting and the high-risk adjuvant setting.
- Interactive panel discussions following each case study, giving you the opportunity to hear different clinical perspectives and ask questions of our expert faculty.
Don’t miss this opportunity to gain valuable insights from leading specialists, explore practical approaches to managing HER2-positive early breast cancer, and connect with colleagues from across the oncology community. We look forward to seeing you there!
Meet our Guest Speakers
We are pleased to introduce the following speakers at the AstraZeneca | Daiichi-Sankyo sponsored Lunch Symposium.
Nadia Harbeck
International Guest Speaker
Nadia Harbeck
International Guest Speaker
Nadia Harbeck, MD, PhD, is Director of the Breast Center, the Center for Hereditary Breast and Ovarian Cancer, and holds the chair for Conservative Oncology at the Department of OB&GYN, LMU University Hospital, Munich, Germany. She obtained her specialist degree (OB&GYN) at the Technical University of Munich (TUM) and her medical degree from the Ludwig-Maximilians-University of Munich (LMU).
Professor Harbeck is the current chair of the ESMO (European Society for Medical Oncology) Early Breast Cancer Faculty; she served as ESMO Director of Education and member of the ESMO Executive Board (2023-2025) as well as Subject Editor of the ESMO Breast Cancer Guidelines (2022-2025). She was a member of the ASCO Annual Meeting Educational Committee (2022-2025). She is a member of the expert panel issuing the German AGO recommendations for breast cancer therapy (www.ago-online.de). She is co-director of the West German Study Group (www.wsg-online.com). From 2009-2015, she served on the EORTC Executive Board as chair of the Translational Research Division. Professor Harbeck is a principal investigator or steering committee member of numerous breast cancer trials, particularly with novel targeted compounds and individualized treatment strategies. She has a strong interest in eHealth and is a co-developer of CANKADO, an international digital patient diary (www.cankado.com).
Professor Harbeck is one of the most frequently cited clinical researchers worldwide (Highly Cited Researcher 2021-2024). She has authored more than 780 papers in peer-reviewed journals (h-index 103) and is coordinating editor-in-chief of Breast Care (Karger Publishers). She co-directed the annual ESMO AACR EORTC Methods in Clinical Cancer Research Workshop (MCCR) from 20218-2019 and 2022-2024 and is a panel member of several international breast cancer consensus conferences.
In 2025, Prof. Harbeck received the Bavarian Order of Merit from the Governor of Bavaria, Germany. She is an Adjunct Professor of the University of Vienna, Austria, and a recipient of the 2023 German Cancer Award and the 2020 ESMO Lifetime Achievement Award. She received several additional recognitions of her clinical and translational research, such as the 2021 UPO Award for Women in Academy and Research, the 2015 Bavarian Cancer Patient Award, the 2012 Claudia von Schilling Award, the 2008 EBCC Award, the 2002 AGO Schmidt-Matthiesen Award, a 2001 AACR Award, and the 2001 ASCO Fellowship Merit Award for the highest ranking abstract.
Bruce Mann
Conference Guest Speaker
Bruce Mann
Conference Guest Speaker
Bruce Mann is Professor of Surgery at the University of Melbourne and Director of the Breast Service at the Royal Melbourne and Royal Women’s Hospitals.
He is also Director of Research at Breast Cancer Trials – Australia and New Zealand’s cooperative breast cancer clinical trials organisation.
His interests relate to systems for optimal breast cancer care and research to improve early diagnosis and tailor the extent of breast cancer treatment to the individual patient.
Gillian Lamoury
Conference Guest Speaker
Gillian Lamoury
Conference Guest Speaker
Associate Professor Gillian Lamoury is a Senior Staff Specialist, Radiation Oncologist at Royal North Shore Hospital, a VMO at Mater, North Sydney, and regionally in Western NSW, with a subspecialty interest in the treatment of breast cancer.
Gillian is a Clinical Associate Professor at the University of Sydney. She is the Principal Investigator on several international, national, and investigator-led trials.
She is passionate about patient-centred, evidence-based care, including the delivery of high-quality treatments through advanced radiation therapy techniques for breast cancer.
Her philanthropic interests and passion for equitable access to high-quality cancer treatments led her to accept a Board position on the GenesisCare Foundation in 2020.
In 2025, she was appointed to the Board of Pratham Australia, a volunteer run, non-profit, charitable organisation whose vision is to end the cycle of poverty in India by providing access to education.
Gillian advocates for better patient care through her work with several important strategic groups. She was the inaugural Chair of the Breast Interest Group - Faculty of Radiation Oncology (BIG-FRO), which aims to promote best practice for breast cancer management, and to enhance the profile of radiation oncology for treating breast cancer. She is the recent past Chair of the Breast Cancer Advisory Group (Cancer Australia 2018 -2020) and is a member of the Clinical Advisory Group for Breast Cancer Network Australia (BCNA).
Antonia Pearson
Symposium Guest Speaker
Antonia Pearson
Symposium Guest Speaker
Antonia completed her medical oncology training at Royal North Shore Hospital, Sydney, before undertaking a clinical trials fellowship.
She has a particular interest in caring for people with breast, lung, gastrointestinal, and gynaecological malignancies. She is an active member of several multidisciplinary teams at the Northern Beaches Hospital and Royal North Shore Hospital.
Antonia is a Senior Clinical Lecturer at Macquarie University, a Clinical Associate Lecturer at the University of Sydney and is actively involved in teaching medical students.
She is the Director of Physician Education at Northern Beaches Hospital. In 2025 she completed her PhD at the University of Sydney in survivorship issues and clinical trials in women with breast cancer.
Antonia believes strongly in a patient-centred and collaborative approach to caring for people with cancer.
She understands that each patient is a unique individual and works with her patients to achieve the best outcomes for them. Antonia prioritises communication, patient advocacy and multidisciplinary collaboration to provide the best medical care for her patients.